Analysts have clear opinions on VYGR.
Based on 5 analysts offering 12 month price targets for VYGR in the last 3 months. The average price target is $30.00 with a high estimate of $37.00 and a low estimate of $26.00.
Voyager Therapeutics, Inc. (VYGR) is followed by 5 analysts on the street. Their average price target to be reached in the next 12 months has a
Phil Nadeau from Cowen & Co. rates it a Buy with a target of —.
Similarly, 25 days ago Jeffrey Hung of Morgan Stanley Reiterated a Hold with a target of $26.00.
The consensus on the street is Strong Buy.
What does Voyager Therapeutics, Inc.(VYGR) do ?
Voyager Therapeutics, Inc. operates as a clinical-stage gene therapy company, which develops treatments for patients suffering from central nervous system. Its pipeline of gene theraphy programs include VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program,
Voyager Therapeutics, Inc.(VYGR) Insider Trades
Multiple company employees have indulged in significant insider trading. Voyager Therapeutics, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that:
10%, Neurocrine Biosciences Inc : P – Purchase(+$49,999,996) of VYGR in the trading session of 2019-03-12.
Dir Geraghty James A : P – Purchase(+$58,170) of VYGR in the trading session of 2018-09-10.
Dir Pierce Glenn : P – Purchase(+$92,200) of Voyager Therapeutics, Inc. in the trading session of 2018-09-12.
Looking for stocks just like VYGR? [Info can be found here: https://www.tipranks.com/stocks/VYGR/similar-stocks ]
Based on analyst reserch, several stocks are similar to VYGR
– RGNX [Info can be found here: https://www.nasdaq.com/market-activity/stocks/RGNX ]
– SGMO [Info can be found here: https://www.nasdaq.com/market-activity/stocks/SGMO ]
– CYTK [Info can be found here: https://www.nasdaq.com/market-activity/stocks/CYTK ]